Suchergebnisse - Karl Kieburtz

Treffer weiter einschränken
  1. 1
    A Randomized, Placebo-Controlled Trial of Latrepirdine in Huntington Disease

    A Randomized, Placebo-Controlled Trial of Latrepirdine in Huntington Disease von Karl Kieburtz

    Veröffentlicht 2010
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  2. 2
    The relationship between uric acid levels and Huntington's disease progression

    The relationship between uric acid levels and Huntington's disease progression von Peggy Auinger, Karl Kieburtz, Michael McDermott

    Veröffentlicht 2010
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  3. 3
    A review of disease progression models of Parkinson's disease and applications in clinical trials

    A review of disease progression models of Parkinson's disease and applications in clinical trials von Charles S. Venuto, Nicholas B. Potter, E. Ray Dorsey, Karl Kieburtz

    Veröffentlicht 2016
    Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  4. 4
    The relationship between CAG repeat length and clinical progression in Huntington's disease

    The relationship between CAG repeat length and clinical progression in Huntington's disease von Bernard Ravina, Megan Romer, Radu Constantinescu, Kevin Biglan, Alicia Brocht, Karl Kieburtz, Ira Shoulson, Michael McDermott

    Veröffentlicht 2008
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Levodopa and the Progression of Parkinson's Disease

    Levodopa and the Progression of Parkinson's Disease von Stanley Fahn, David Oakes, Ira Shoulson, Karl Kieburtz, Alice Rudolph, Anthony E. Lang, C. Warren Olanow, Caroline M. Tanner, Kenneth Marek

    Veröffentlicht 2004
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  6. 6
    Moving Parkinson care to the home

    Moving Parkinson care to the home von E. Ray Dorsey, Floris P. Vlaanderen, Lucien JLPG Engelen, Karl Kieburtz, William Zhu, Kevin Biglan, Marjan J. Faber, Bastiaan R. Bloem

    Veröffentlicht 2016
    Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  7. 7
    Prevalence of dementia in rural China: impact of age, gender and education

    Prevalence of dementia in rural China: impact of age, gender and education von Dao Zhou, Ching‐Fen Wu, Haitao Qi, Jin‐Hu Fan, X. D. Sun, Peter G. Como, You‐Lin Qiao, Lu Zhang, Karl Kieburtz

    Veröffentlicht 2006
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  8. 8
    Trinucleotide repeat length and progression of illness in Huntington's disease.

    Trinucleotide repeat length and progression of illness in Huntington's disease. von Karl Kieburtz, Marcy E. MacDonald, Chiu-Yang Shih, Andrew Feigin, Kim Steinberg, Kathy Bordwell, Carol Zimmerman, Jayalakshmi Srinidhi, Jenny Sotack, James F. Gusella

    Veröffentlicht 1994
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  9. 9
    Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort

    Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort von Tanya Simuni, Chelsea Caspell‐Garcia, Christopher S. Coffey, Daniel Weintraub, Brit Mollenhauer, Shirley Lasch, Caroline M. Tanner, Danna Jennings, Karl Kieburtz, Lana M. Chahine, Kenneth Marek

    Veröffentlicht 2017
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  10. 10
    The Idiopathic Intracranial Hypertension Treatment Trial

    The Idiopathic Intracranial Hypertension Treatment Trial von Deborah I. Friedman, Michael McDermott, Karl Kieburtz, Mark J. Kupersmith, Ann Stoutenburg, John L. Keltner, Steven E. Feldon, Eleanor Schron, James J. Corbett, Michael Wall

    Veröffentlicht 2014
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  11. 11
    The Idiopathic Intracranial Hypertension Treatment Trial

    The Idiopathic Intracranial Hypertension Treatment Trial von Michael Wall, Mark J. Kupersmith, Karl Kieburtz, James J. Corbett, Steven E. Feldon, Deborah I. Friedman, David M. Katz, John L. Keltner, Eleanor Schron, Michael McDermott

    Veröffentlicht 2014
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  12. 12
    Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss

    Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss von Michael Wall, Michael McDermott, Karl Kieburtz, James J. Corbett, Steven E. Feldon, Deborah I. Friedman, David M. Katz, John L. Keltner, Eleanor Schron, Mark J. Kupersmith

    Veröffentlicht 2014
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  13. 13
    Results of the citalopram to enhance cognition in Huntington disease trial

    Results of the citalopram to enhance cognition in Huntington disease trial von Leigh J. Beglinger, William Adams, Douglas R. Langbehn, Jess G. Fiedorowicz, Ricardo E. Jorge, Kevin Biglan, John N. Caviness, Blair Olson, Robert G. Robinson, Karl Kieburtz, Jane S. Paulsen

    Veröffentlicht 2013
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  14. 14
    Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

    Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease von Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Rema Raman, Xiaoying Sun, Paul Aisen, Eric Siemers, Hong Liu‐Seifert, Richard C. Mohs

    Veröffentlicht 2014
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  15. 15
    A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

    A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease von Rachelle S. Doody, Rema Raman, Martin R. Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Feng He, Xiaoying Sun, Ronald G. Thomas, Paul Aisen, Eric Siemers, Gopalan Sethuraman, Richard C. Mohs

    Veröffentlicht 2013
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  16. 16
    A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease

    A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease von Peter A. LeWitt, Robert A. Hauser, Donald G. Grosset, Fabrizio Stocchi, Marie Saint‐Hilaire, Aaron Ellenbogen, Mika Leinonen, Neil B. Hampson, Tia DeFeo-Fraulini, Martin I. Freed, Karl Kieburtz

    Veröffentlicht 2016
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  17. 17
    Trichloroethylene: An Invisible Cause of Parkinson’s Disease?

    Trichloroethylene: An Invisible Cause of Parkinson’s Disease? von E. Ray Dorsey, Maryam Zafar, Samantha E. Lettenberger, Meghan Pawlik, Dan Kinel, Myrthe Frissen, Ruth B. Schneider, Karl Kieburtz, Caroline M. Tanner, Briana R. De Miranda, Samuel M. Goldman, Bastiaan R. Bloem

    Veröffentlicht 2023
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  18. 18
    HIV-associated cognitive impairment before and after the advent of combination therapy

    HIV-associated cognitive impairment before and after the advent of combination therapy von Ned Sacktor, Michael McDermott, Karen Marder, Giovanni Schifitto, Ola A. Selnes, Justin C. McArthur, Yaakov Stern, Steven M. Albert, Donna Palumbo, Karl Kieburtz, Joy Antonelle de Marcaida, Bruce A. Cohen, Leon G. Epstein

    Veröffentlicht 2002
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  19. 19
    Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

    Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study von C. Warren Olanow, Karl Kieburtz, Per Odin, Alberto J. Espay, David G. Standaert, Hubert H. Fernandez, Arvydas Vanagunas, Ahmed A. Othman, Katherine L. Widnell, Weining Robieson, Yili Pritchett, Krai Chatamra, Janet Benesh, Robert Lenz, Angelo Antonini

    Veröffentlicht 2013
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  20. 20
    Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia

    Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia von Jeffrey Sevigny, Steven M. Albert, Michael McDermott, Justin C. McArthur, Ned Sacktor, Kathy Conant, Giovanni Schifitto, Ola A. Selnes, Yaakov Stern, Daniel McClernon, Donna Palumbo, Karl Kieburtz, Garrett Riggs, Bevin Cohen, Leon G. Epstein, Karen Marder

    Veröffentlicht 2004
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: